Novo Nordisk reprimanded in the UK
Danish drugmaker Novo Nordisk has been reprimanded by British regulators for failing to disclose fees and expenses paid to healthcare professionals and healthcare organisations in Britain, amounting to about 7.8 million pounds between 2020 and 2022.
ПОПУЛЯРНЫЕ ПОСТЫ
Putin may discuss Ukraine peace deal with Trump
Ноябрь 22, 2024
Spain’s vice-president Ribera blames floods on climate change
Ноябрь 22, 2024
Storm lashes northwestern US, killing two people
Ноябрь 22, 2024
Iceland volcano erupts for tenth time in three years
Ноябрь 22, 2024
ПОДПИСЫВАЙТЕСЬ НА НАС
ПРЯМАЯ ТРАНСЛЯЦИЯ